A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection and Cisplatin Combined with Cadonilimab As a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: a Single-Arm, Single-Center, Prospective Clinical Trial (POINTS Trial)
Latest Information Update: 28 Feb 2025
At a glance
- Drugs Cadonilimab (Primary) ; Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms POINTS
Most Recent Events
- 24 Feb 2025 Planned End Date changed from 20 Jun 2025 to 20 Jun 2027.
- 24 Feb 2025 Planned primary completion date changed from 20 Apr 2025 to 20 Apr 2027.
- 24 Feb 2025 Planned initiation date changed from 20 Apr 2024 to 20 Apr 2025.